Stock listing
BOLT Stock Price, News, Filings & Events — Bolt Biotherapeutics, Inc.
Selected listing: BOLT · NASDAQ · USD · US
This page tracks Bolt Biotherapeutics, Inc.'s BOLT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BOLT:NASDAQ. BOLT:NASDAQ is the stock-level entry point for investors researching Bolt Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bolt Biotherapeutics, Inc. is a public company traded under the ticker BOLT in the American market. The company has a market capitalization of approximately $7.36 million. Bolt Biotherapeutics focuses on developing innovative therapies in the biotherapeutics sector.
- Ticker
- BOLT:NASDAQ
- Asset type
- Stock
- Market cap
- $7.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Bolt Biotherapeutics, Inc. BOLT:NASDAQ stock context
This page tracks Bolt Biotherapeutics, Inc.'s BOLT:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BOLT:NASDAQ. BOLT:NASDAQ is the stock-level entry point for investors researching Bolt Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bolt Biotherapeutics, Inc. is a public company traded under the ticker BOLT in the American market. The company has a market capitalization of approximately $7.36 million. Bolt Biotherapeutics focuses on developing innovative therapies in the biotherapeutics sector.
Latest news from Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
March 12, 2026
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 1, 2025
Bolt Biotherapeutics, Inc. earnings calls
Research Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. investor report
Review AI stock analysis and investor report context for BOLT:NASDAQ.
Bolt Biotherapeutics, Inc. company profile
View the public company page for Bolt Biotherapeutics, Inc. on 6ix.
Bolt Biotherapeutics, Inc. news
Read company news and market updates connected to Bolt Biotherapeutics, Inc..
Bolt Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Bolt Biotherapeutics, Inc..
Alternate listings
BOLT:BOATS
US · USD
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.
6LP0:FWB
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.
6LP0:GETTEX
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.
A419U9:LS
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.
A419U9:LSX
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.
6LP0:MUN
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is BOLT:NASDAQ.